Nutrison Concentrated

A nutritionally complete, very high energy, low mineral, ready-to-use enteral tube feed.
  • Suitable as a sole source of nutrition.^
  • 2kcal/ml: for patients with increased energy requirements and fluid/volume restrictions.
  • Whey-dominant P4 protein blend: in line with international recommendations on protein quality/amino acid profile and for gastro-intestinal tolerance benefits. 1-8
  • Flocare Two Pack Connector (69915) compatible: for connecting two packs (2x 500ml) for simultaneous delivery.

Product Information

A nutritionally complete, very high energy, low mineral, ready-to-use enteral tube feed.

Link copied!
Indications

For use in the dietary management of:

  • Disease-related malnutrition.
  • Conditions requiring a fluid or volume restriction e.g. liver or renal disease, heart failure.
  • Conditions requiring a select mineral restriction e.g. renal disease.
Important Notice
  • Not for parenteral use.
  • Not suitable for patients with galactosaemia.
  • Not suitable for use in patients with cow’s milk protein allergy.
  • Not suitable for infants under 1 year of age.
  • Use with caution in children aged 1-6 years of age.
  • Use with caution in individuals with a seafood allergy.
Direction for Use
  • Shake well before use.
  • Use at room temperature.
  • Handle aseptically to ensure product remains sterile.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, store in the refrigerator.
  • Discard unused content after 24 hours.
Order Information

Contact Nutricia Customer Care 1800 889 480

Nutrison Concentrated  Product Code  Units per carton 
500ml OpTri bottle  132376  12 
Ingredients

Full ingredients list and nutritional information available on Factsheet.

Allergen & Cultural Information
  • Contains: cow’s milk protein, soy, fish oil.
  • Does not contain: wheat, egg, nuts*, lupins.
  • Halal certified.
  • No Kosher forbidden ingredients.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose < 2g/100g).
References
  1. 1.Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
  2. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
  3. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
  4. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
  5. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutrition formulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
  6. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
  7. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119)
  8. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5

 
* Peanut (Arachis hypogaea), Almond (Amygdalus communis L .), Hazelnut (Corylus avellana), Walnut (Juglans regia), Cashew (Anacardium occidentale), Pecan nut (Carya illinoiesis (Wangenh.) K. Koch), Brazil nut (Bertholletia excelsa), Pistachio nut (Pistacia vera), Macadamia nut and Queensland nut (Macadamia ternifolia), and products thereof.